| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.086 | 0.1 |